Effects of the time of antihypertensive drugs administration on the stage of primary open-angle glaucoma in patients with arterial hypertension

Blood Pressure

Volumn 21, Issue 4, 2012, Pages 240-248

  Krasińska, Beata ^a   Karolczak Kulesza, Małgorzata ^a   Krasiński, Zbigniew ^a   Pawlaczyk Gabriel, Katarzyna ^a   Łopatka, Paweł ^a   Głuszek, Jerzy ^a   Tykarski, Andrzej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chronotherapy; Glaucoma; Hypertension; Hypotensive drugs; Visual field defects

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; PERINDOPRIL; PROSTAGLANDIN DERIVATIVE; RAMIPRIL; VALSARTAN;

ADULT; AGED; AMPLITUDE MODULATION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DIURETIC THERAPY; DRUG EFFICACY; DRUG SAFETY; EVENING DOSAGE; EVOKED VISUAL RESPONSE; EYE BLOOD FLOW; EYEBALL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; ORBIT; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VISUAL FIELD; VISUAL IMPAIRMENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DRUG CHRONOTHERAPY; EYE; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OPTIC NERVE; ORBIT; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84864201009     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.666423     Document Type: Article

References (54)

1. Hulsman CA, Vingerling JR, Hofman A. Blood pressure, arterial stiffness and open-angle glaucoma: The Rotterdam Study. Arch. Ophthalmol. 2007;125:805-812. (Pubitemid 46919742)
2. Dielemans I, Vingerling J.R, Algra D. Primary open-angle glaucoma, intraocular pressure and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology. 1995;102:54 - 60.
3. Salim S, Shields B. Glaucoma and systemic disease. Surv. Ophthalmol. 2010;55:64-77.
4. Kitazawa Y, Horie T, Aoki S, Suzuki M, Nishioka K. Untreated ocular hypertension: A long term prospective study.Arch. Ophthalmol.1977;95:1180-1184. (Pubitemid 8143724)
5. Martinez-Bello C, Chauhan BC, Nicolela MT. Intraocular pressure and progression of glaucomatous visual fi eld loss. Am J Ophthalmol. 2000;129:302-308. (Pubitemid 30126074)
6. Wolf S. Retinal hemodynamics using scanner laser ophthalmoscopy and hemorheology in chronic open angle glaucoma. Ophthalmology. 1993;100:1561-1566. (Pubitemid 23292867)
7. Duijm HF, Vandenberg TJ, Greve EL. Choroidal hemodynamics in glaucoma. Br J Ophthalmol. 1997;81:735-742.
8. Pruente C.H, Flammer J. Choroidal angiography fi ndings in patients with glaucoma-like visual fi eld defects. Perimetry Update 1988/1989. Amstelveen Kugler and Ghedini. 1989; 325-327.
9. Ulrich C.H. Stoerung der peripapillaeren Mikrozilkulation bei Glaukomapatienten. Ophthalmologe. 1993;90:45-50.
10. Emre M, Sorgul K. Ocular blood fl ow alteration in glaucoma is related to systemic vascular deregulations. Br J Ophthalmol. 2004;88:662-666. (Pubitemid 38526650)
11. Gasser P. Why study vascular factor in glaucoma? Int Ophthalmol. 1999;22:221-225.
12. Plange N, Kaup M, Daneljan L, Predelhttp://www.nature. com/jhh/journal/v20/n2/full/1001959a.html - aff2 HG, Remkyhttp:// www.nature.com/jhh/journal/v20/n2/full/1001959a. html - aff1 A, Arend O. 24-h blood pressure monitoring in normal tension glaucoma: Night-time blood pressure variability. J Human Hypertens. 2006;20:137-142. (Pubitemid 43148615)
13. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic signifi cance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens. 2002;20:2183-2189. (Pubitemid 35388236)
14. Tykarski A, Kostka - Jeziorny K, Kawecka-Jaszcz K. Chronotherapy of arterial hypertension. Arterial Hypertens. 2006;10: 235-250. (Pubitemid 44639160)
15. Hayreh SS. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol. 1999;10:474-82.
16. Hayreh S.S, Podhajsky P, Zimmerman M.B. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999;213:76-96. (Pubitemid 29049393)
17. Bresson-Dumont H, Bechtoille A. Arterial hypotension in glaucoma of normal or moderately high pressure. J Fr Ophtalmol. 1995;18:128-34.
18. Choi J, Joeng J, Cho H. Effect of nocturnal blood pressure reduction on circadian fl uctuation of mean ocular perfusion pressure: A risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci. 2006;47:831-83.
19. Choi J, Hoon K, Jeong J. Circadian fl uctuation of mean ocular perfusion pressure is a consistent risk factor for normaltension glaucoma invest. Ophthalmol Vis Sci. 2007;48: 104-111. (Pubitemid 47251393)
20. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of arterial hypertension of the European Society of Hypertension/European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2007;25:1105-1187. (Pubitemid 46924065)
21. Krasinska B, Karolczak-Kulesza M, Krasi s ki Z, Pawlaczyk- Gabriel K, Niklas A, G l uszek J, et al. A marked fall in nocturnal blood pressure is associated with the stage of primary open angle glaucoma in patients with arterial hypertension. Blood Press. 2010;20:171-181.
22. Steigerwalt R, Belcaro G, Laurora G. Ocular and orbital blood fl ow in patients with essential hypertension treated with trandolapril. Retina.1998;18:539-545. (Pubitemid 30387559)
23. Leighton DA, Phillips CI. Systemic blood pressure in openangle glaucoma, low tension glaucoma and the normal eye. Br. J Opththamol. 1972;56:447-453.
24. B onomi L, Marchini G, Maraffa M, Bernardi P, Morbio P, Varotto A.. Vascular risk factors for primary open angle glaucoma, the Egnna Neumarkt Study. Ophthalmology. 2000;107; 1287-1293.
25. Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: The Blue Mountains eye study. J Glaucoma. 2004;13:319-323.
26. Karadeniz-Bilgili M, Ekmekci Y, Koksal A. Effects of hypertension and antihypertensive treatment on retrobulbar circulation detected on Doppler sonography. J Ultrasound Med. 2004;23:13-17. (Pubitemid 38113820)
27. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure and primary open glaucoma. Arch Ophthalmol. 1995;113:216-221.
28. Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer ' s disease and Parkinson ' s disease. Am J Ophthalmol. 2002;133:135-137. (Pubitemid 34076513)
29. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K, Epstein DL. A case control study of risk factors in open angle glaucoma. Arch Ophthalmol. 1987;105:1066-1071. (Pubitemid 17136382)
30. Wong T, Mitchell P. The eye study in hypertension. Lancet. 2007;369:425-435.
31. Hennis A, Wu SY, Nemesure B, Leske MC. Barbados Eye Studies Group. Hypertension, diabetes and longitudinal changes in intraocular pressure. Ophthalmol. 2003;110: 908-914. (Pubitemid 36560487)
32. Wu S, Nemesure B, Hennis A, Leske MC. Barbados Eye Studies Group. Nine year changes in intraocular pressure: The Barbados Eye Studies. Arch Ophthalmol. 2006;124: 1631-163.
33. Topouzis F, Coleman AL, Harris A, Jonescu-Cuypers C, Yu F, Mavroudis L, et al. Association of blood pressure status with the optic disc structure in non glaucoma subjects:The Thessaloniki eye study. Am J Ophthalmol. 2006;142:60-66.
34. Galassi F, Sodi A, Ucci F, Renieri G, Pieri B, Baccini M. Ocular hemodynamics and glaucoma prognosis: A color Doppler imaging study. Arch Ophthalmol. 2003;121:1711-1715. (Pubitemid 37517437)
35. Coca A. Circadian rhythm and blood pressure control: Physiological and pathophysiological factors. J Hypertens. 1994;12 Suppl 5:13-21.
36. O' B rien EO, Sheridan J, O' M alley K. Dippers and non-dippers. Lancet. 1988;2:397-399 .
37. Roman MJ, Pickering TG, Schwartz JE, Cavallini MC, Pini R, Devereux RB. Is the absence of nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage? J Hypertens. 1997;15:969-978. (Pubitemid 27399811)
38. Smolensky MH. Chronobiology and chronotherapeutics applications to cardiovascular medicine. Am J Hypertens. 1996;9:11-21.
39. Gherghel D, Orgul S, Gugleta K, Flammer J. Retrobulbar blood fl ow in glaucoma patients with nocturnal over-dipping in systemic blood pressure Am J Ophthtalmol. 2001;132: 641-647. (Pubitemid 33031280)
40. Pache M, Flammer J. A sick eye in a sick body ? Systemic fi ndings in patients with primary open-angle glaucoma. Ophthalmol. 1984;91:1690-1694.
41. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994; 117:603-624. (Pubitemid 24150730)
42. Bechetoille A, Bresson-Dumont H. Diurnal and nocturnal blood pressure drops in patients with focal ischemic glaucoma. Graefes Arch Clin Exp Ophthalmol. 1994;232: 675-679. (Pubitemid 24313572)
43. Graham SL, Drance SM, Wijsman K, Douglas GR, Mikelberg FS. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmology. 1995;102:61-69.
44. Meyer JH, Brandi-Dohrn J, Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma. Br. J Ophthalmol. 1996;80:864-867. (Pubitemid 26366552)
45. Graham SI, Drance SM. Nocturnal hypotension: Role in glaucoma progression. Surv Ophthalmol. 1999;43:10-16.
46. Kaiser HJ, Schoetzau A, Stumpfi g D, Flammer J. Blood fl ow velocities of the extraocular vessels in patients with hightension and normal tension primary open glaucoma Am J Ophthalmol. 1997;123:320-327. (Pubitemid 27123038)
47. Logan JF, Rankin SJ, Jackson AJ. Retinal blood fl ow measurements rim damage in glaucoma Br J Ophthalmol. 2004;88: 1049-1054. (Pubitemid 39013148)
48. Plange N. Papillare Fullungsdefekte in Fluoreszein Angiographien bei Glaukom-Eine retrospektive klinische Studie. Klinische Monatsblatter fuer Augenheilkunde. 2001;218: 214-221. (Pubitemid 32441022)
49. Galassi F, Nuzzaci G, Sodi A, Casi P, Vielmo A. Color Doppler imaging in evaluation of nerve blood supply in normal and glaucomatous subjects. Int. Ophthalmol. 1992;16: 237-276.
50. Yamazaki Y, Hayamizu F. Analysis of ophthalmic arterial fl ow by color Doppler imaging in glaucomatous eyes (in Japanese). Nippon Ganka Gakkai Zasshi. 1994;98:1115-1120. (Pubitemid 24353783)
51. Nicolea MT, Walman BE, Buckley AR, Drance SM. Ocular hypertension and primary open-angle glaucoma: A comparative study of their retrobulbar blood fl ow velocity. J Glaucoma. 1996;5:308-310. (Pubitemid 26364640)
52. Matthiessen ET, Zeitz O, Richard G, Klemm M. Reproducibility of blood fl ow velocity measurements using color decoded Doppler imaging. Eye. 2004;18:400-405. (Pubitemid 38585016)
53. Hayreh SS. Progress in the understanding of the vascular etiology of glaucoma Curr Opin Ophthalmol. 1994;5II: 26-35. (Pubitemid 24178229)
54. Grunwald JE, Piltz J, Hariprasad SM, Doupont J, Maguire MG. Optic nerve blood fl ow in glaucoma: Effect of systemic hypertension. Am J Ohthalmol. 1999;127:516-522. (Pubitemid 29215761)